|
[1]PARKIN DM.Global cancer statistics in the year 2000[J].Lancet Oncol, 2001, 2 (9) :533-543.
|
|
[2]WANG J, CHAN JY, FONG CC, et al.Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines[J].Liver Int, 2009, 29 (9) :1338-1347.
|
|
[3]BOSCH FX, RIBES J, CLERIES R, et al.Epidemiology of hepatocellular carcinoma[J].Clin Liver Dis, 2005, 9 (2) :191-211.
|
|
[4]BOREL F, KONSTANTINOVA P, JANSEN PL.Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma[J].J Hepatol, 2012, 56 (6) :1371-1383.
|
|
[5] SCHWARTZ M, ROAYAIE S, KONSTADOULAKIS M.Strategies for the management of hepatocellular carcinoma[J].Nat Clin Prac Oncol, 2007, 4 (7) :424-432.
|
|
[6] POON RT, FAN ST.Hepatectomy for hepatocellular carcinoma:patient selection and postoperative outcome[J].Liver Transpl, 2004, 10 (2 Suppl 1) :s39-s45.
|
|
[7]YUEN MF, CHENG CC, LAUDER IJ, et al.Early detection of hepatocellular carcinoma increases the chance of treatment:Hong Kong experience[J].Hepatology, 2000, 31 (2) :330-335.
|
|
[8]FUKUDA S, ITAMOTO T, NAKAHARA H, et al.Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma[J].Hepatogastroenterology, 2005, 52 (64) :1163-1167.
|
|
[9]COLLIER J, SHERMAN M.Screening for hepatocellular carcinoma[J].Hepatology, 1998, 27 (1) :273-278.
|
|
[10]OKA H, TAMORI A, KUROKI T, et al.Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma[J].Hepatology, 1994, 19 (1) :61-66.
|
|
[11]ABDALLA MA, HAJ-AHMAD Y.Promising candidate urinary microrna biomarkers for the early detection of hepatocellular carcinoma among high-risk hepatitis C virus Egyptian patients[J].J Cancer, 2012, 3:19-31.
|
|
[12]KASAHARA A, HAYASHI N, FUSAMOTO H, et al.Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes[J].Dig Dis Sci, 1993, 38 (12) :2170-2176.
|
|
[13]BRUIX J, LLOVET JM.Prognostic prediction and treatment strategy in hepatocellular carcinoma[J].Hepatology, 2002, 35 (3) :519-524.
|
|
[14]LIU J, ZHENG M, TANG YL, et al.MicroRNAs, an active and versatile group in cancers[J].Int J Oral Sci, 2011, 3 (4) :165-175.
|
|
[15]BRACONI C, HENRY JC, KOGURE T, et al.The role of microRNAs in human liver cancers[J].Semin Oncol, 2011, 38 (6) :752-763.
|
|
[16]MELO SA, ESTELLER M.Dysregulation of microRNAs in cancer:playing with fire[J].FEBS Lett, 2011, 585 (13) :2087-2099.
|
|
[17]WANG J, SEN S.MicroRNA functional network in pancreatic cancer:from biology to biomarkers of disease[J].J Biosci, 2011, 36 (3) :481-491.
|
|
[18] FORNARI F, MILAZZO M, CHIECO P, et al.MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells[J].Cancer Res, 2010, 70 (12) :5184-5193.
|
|
[19]CHEN P, ZHAO X, MA L.Downregulation of microRNA-100correlates with tumor progression and poor prognosis in hepatocellular carcinoma[J].Mol Cell Biochem, 2013, 383 (1-2) :49-58.
|
|
[20]CHEN XM.MicroRNA signatures in liver diseases[J].World J Gastroenterol, 2009, 15 (14) :1665-1672.
|
|
[21]KIM CJ, PARK NH, CHUNG YH.Roads towards a new tailored therapy for hepatocellular carcinoma:diagnostic, therapeutic and prognostic implications of microRNAs[J].Liver Int, 2012, 32 (5) :695-697.
|
|
[22]AUGELLO C, VAIRA V, CARUSO L, et al.MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma[J].Liver Int, 2012, 32 (5) :772-782.
|
|
[23] DATTA J, KUTAY H, NASSER MW, et al.Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis[J].Cancer Res, 2008, 68 (13) :5049-5058.
|
|
[24]KIM WH, MIN KT, JEON YJ, et al.Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population[J].Gene, 2012, 504 (1) :92-97.
|
|
[25]XU J, ZHU X, WU L, et al.MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway[J].Liver Int, 2012, 32 (5) :752-760.
|
|
[26]BALA S, MARCOS M, SZABO G.Emerging role of microRNAs in liver diseases[J].World J Gastroenterol, 2009, 15 (45) :5633-5640.
|
|
[27] XIONG Y, FANG JH, YUN JP, et al.Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma[J].Hepatology, 2010, 51 (3) :836-845.
|
|
[28]HUANG XM, CHEN X, JIA ZY.Progress of artificial microRNAs in cancer gene therapy[J].Chin J Cell Biol, 2013, 35 (7) :1018-1026. (in Chinese) 黄晓明, 陈翔, 贾振宇.人工microRNAs在肿瘤基因治疗中的研究[J].中国细胞生物学学报, 2013, 35 (7) :1018-1026.
|
|
[29]ZHUANG P, LI ZY, WANG XC, et al.The functional characterization of the human liver-specific miR-122 expression in hepatocullar carcinoma[J].Chin J immunol, 2013, 29 (7) :686-688. (in Chinese) 庄鹏, 李志莹, 王湘郴, 等.肝特异性的miR-122对肝癌细胞增殖及凋亡的影响[J].中国免疫学杂志, 2013, 29 (7) :686-688.
|
|
[30] CHEN X, BA Y, MA L, et al.Characterization of microRNAs in serum:a novel class of biomarkers for diagnosis of cancer and other diseases[J].Cell Res, 2008, 18 (10) :997-1006.
|
|
[31] MITCHELL PS, PARKIN RK, KROH EM, et al.Circulating microRNAs as stable blood-based markers for cancer detection[J].Proc Natl Acad Sci U S A, 2008, 105 (30) :10513-10518.
|
|
[32] LU J, GETZ G, MISKA EA, et al.MicroRNA expression profiles classify human cancers[J].Nature, 2005, 435 (7043) :834-838.
|
|
[33]LI J, SMYTH P, FLAVIN R, et al.Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells[J].BMC Biotechnol, 2007, 7:36.
|
|
[34]XI Y, NAKAJIMA G, GAVIN E, et al.Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples[J].RNA, 2007, 13 (10) :1668-1674.
|
|
[35] ZHOU J, YU L, GAO X, et al.Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma[J].J Clin Oncol, 2011, 29 (36) :4781-4788.
|
|
[36] ZHANG C, WANG C, CHEN X, et al.Expression profile of microRNAs in serum:a fingerprint for esophageal squamous cell carcinoma[J].Clin Chem, 2010, 56 (12) :1871-1879.
|
|
[37] WANG J, CHEN J, CHANG P, et al.MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease[J].Cancer Prev Res (Phila) , 2009, 2 (9) :807-813.
|
|
[38] WEBER JA, BAXTER DH, Zhang S, et al.The microRNA spectrum in 12 body fluids[J].Clin Chem, 2010, 56 (11) :1733-1741.
|
|
[39] CORTEZ MA, BUESO-RAMOS C, FERDIN J, et al.MicroRNAs in body fluids-the mix of hormones and biomarkers[J].Nat Rev Clin Oncol, 2011, 8 (8) :467-477.
|
|
[40]LI J, WANG Y, YU W, et al.Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance[J].Biochem Biophys Res Commun, 2011, 406 (1) :70-73.
|
|
[41]QU KZ, ZHANG K, LI H, et al.Circulating microRNAs as biomarkers for hepatocellular carcinoma[J].J Clin Gastroenterol, 2011, 45 (4) :355-360.
|
|
[42]TOMIMARU Y, EGUCHI H, NAGANO H, et al.Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma[J].J Hepatol, 2012, 56 (1) :167-175.
|
|
[43] XU J, WU C, CHE X, et al.Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis[J].Mol Carcinog, 2011, 50 (2) :136-142.
|
|
[44] QI P, CHENG SQ, WANG H, et al.Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection[J].PLoS One, 2011, 6 (12) :e28486.
|
|
[45] LI LM, HU ZB, ZHOU ZX, et al.Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma[J].Cancer Res, 2010, 70 (23) :9798-9807.
|
|
[46] LIU AM, YAO TJ, WANG W, et al.Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma:a retrospective cohort study[J].BMJ Open, 2012, 2 (2) :e000825.
|
|
[47]MENG F, HENSON R, WEHBE-JANEK H, et al.MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer[J].Gastroenterology, 2007, 133 (2) :647-658.
|
|
[48]LIU C, YU J, YU S, et al.MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma[J].J Hepatol, 2010, 53 (1) :98-107.
|
|
[49]KIM S, LEE UJ, KIM MN, et al.MicroRNA miR-199a*regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2) [J].J Biol Chem, 2008, 283 (26) :18158-18166.
|
|
[50]LI L, GUO Z, WANG J, et al.Serum miR-18a:a potential marker for hepatitis B virus-related hepatocellular carcinoma screening[J].Dig Dis Sci, 2012, 57 (11) :2910-2916.
|
|
[51] GUI J, TIAN Y, WEN X, et al.Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies[J].Clin Sci (Lond) , 2011, 120 (5) :183-193.
|
|
[52] ROSENFELD N, AHARONOV R, MEIRI E, et al.MicroRNAs accurately identify cancer tissue origin[J].Nat Biotechnol, 2008, 26 (4) :462-469.
|
|
[53]ZHUANG P, LI Z, WANG XC, et al.Construction of lentiviral vector carrying miR-122 and function of miR-122 in hepatocellular carcinoma cells[J].J Clin Hepatol, 2013, 29 (7) :529-531. (in Chinese) 庄鹏, 李志莹, 王湘郴, 等.miR-122慢病毒载体的构建及其在肝癌细胞中的作用[J].临床肝胆病杂志, 2013, 29 (7) :529-531.
|
|
[54] NG EK, CHONG WW, JIN H, et al.Differential expression of microRNAs in plasma of patients with colorectal cancer:a potential marker for colorectal cancer screening[J].Gut, 2009, 58 (10) :1375-1381.
|
DownLoad: